Companies in the biotech and pharmaceutical industry are well known for developing and implementing innovative deal structures in order to realise the maximum value from their assets and get products to market. One of those innovative deal structures is geographical licensing. Whilst apparently simple on the face of it, the devil is in the detail.

  . . .

This content is restricted to subscribers. To view this content please register an account.

Register now

If you are already a subscriber, please login below.